Aberrant Histone Methylation in Patients with Graves’ Disease
Open Access
- 24 June 2019
- journal article
- research article
- Published by Wiley in International Journal of Endocrinology
- Vol. 2019, 1-7
Abstract
Background. Graves’ disease (GD) is an organ-specific autoimmune disease. Accumulated data have indicated that aberrant epigenetic modifications are associated with many autoimmune disorders. However, it remains unknown whether histone methylation plays a role in the pathogenesis of GD. In the present study, we aimed to assess histone modification patterns in peripheral blood mononuclear cells (PBMCs) from GD patients. The rate (degree) of H3K4 and H3K9 methylation and the expressions of histone-modifying genes were investigated.Methods. A total of 68 GD patients and 32 healthy controls were enrolled in this study. Global histone H3K4/H3K9 methylation of PBMCs was evaluated by the EpiQuik™ global histone H3K4/H3K9 methylation assay kit. The expressions of histone methyltransferases (HMTs) and histone demethylases (HDMs) at the mRNA level were determined by real-time quantitative polymerase chain reaction.Results. Global histone H3K9 methylation in PBMCs of GD patients was significantly decreased compared with that in the healthy controls (P=0.007). The expressions of HMTs (SUV39H1 and SUV39H2) at the mRNA level were significantly decreased in PBMCs from GD patients compared with healthy controls (PConclusions. These findings firstly suggested that the histone methylation was aberrant in PBMCs of GD patients, which could be possibly attributed to the deregulation of epigenetic modifier genes. Abnormal histone methylation modification may be involved in the pathogenesis of GD.Keywords
Funding Information
- National Natural Science Foundation of China (81471004, 81670722, JSZK2015A02)
- National Natural Science Foundation of China (81471004, 81670722, JSZK2015A02)
- Key Disciplines Development of Shanghai Jinshan District (81471004, 81670722, JSZK2015A02)
This publication has 39 references indexed in Scilit:
- HDAC4 controls histone methylation in response to elevated cardiac loadJournal of Clinical Investigation, 2013
- Epigenetics and Autoimmune DiseasesAutoimmune Diseases, 2012
- Novel Variant of Thyroglobulin Promoter Triggers Thyroid Autoimmunity through an Epigenetic Interferon α-modulated MechanismJournal of Biological Chemistry, 2011
- Chatting histone modifications in mammalsBriefings in Functional Genomics, 2010
- The etiology of autoimmune thyroid disease: A story of genes and environmentJournal of Autoimmunity, 2009
- Aberrant Histone Modifications at the Thyrotropin-Releasing Hormone Gene in Resistance to Thyroid Hormone: Analysis of F455S Mutant Thyroid Hormone ReceptorEndocrinology, 2009
- Lymphocytes From Patients With Type 1 Diabetes Display a Distinct Profile of Chromatin Histone H3 Lysine 9 DimethylationDiabetes, 2008
- Association of the thyroglobulin gene polymorphism with autoimmune thyroid disease in Chinese populationEndocrine, 2008
- Chromatin Modifications and Their FunctionCell, 2007
- HP1 Binding to Chromatin Methylated at H3K9 Is Enhanced by Auxiliary FactorsMolecular and Cellular Biology, 2007